MX2018009304A - Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares. - Google Patents

Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares.

Info

Publication number
MX2018009304A
MX2018009304A MX2018009304A MX2018009304A MX2018009304A MX 2018009304 A MX2018009304 A MX 2018009304A MX 2018009304 A MX2018009304 A MX 2018009304A MX 2018009304 A MX2018009304 A MX 2018009304A MX 2018009304 A MX2018009304 A MX 2018009304A
Authority
MX
Mexico
Prior art keywords
events
cardiovascular diseases
diagnostic
prognostic methods
method includes
Prior art date
Application number
MX2018009304A
Other languages
English (en)
Inventor
Fay Rhyne Rhonda
Agamemnon Magaret Craig
Edward Strobeck John
Louis Januzzi James Jr
Original Assignee
Prevencio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevencio Inc filed Critical Prevencio Inc
Publication of MX2018009304A publication Critical patent/MX2018009304A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/503—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the heart
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

Se proporcionan composiciones y métodos para diagnostico y/o pronóstico de enfermedades o episodios cardiovasculares en un sujeto; en algunas modalidades, el método incluye medir y comparar el nivel de proteínas particulares con otras proteínas; en otras modalidades, el método incluye comparación con información sobre variables clínicas.
MX2018009304A 2016-02-01 2017-02-01 Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares. MX2018009304A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662289513P 2016-02-01 2016-02-01
US201662378535P 2016-08-23 2016-08-23
PCT/US2017/016081 WO2017136464A1 (en) 2016-02-01 2017-02-01 Diagnostic and prognostic methods for cardiovascular diseases and events

Publications (1)

Publication Number Publication Date
MX2018009304A true MX2018009304A (es) 2019-01-10

Family

ID=59500904

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018009304A MX2018009304A (es) 2016-02-01 2017-02-01 Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares.

Country Status (13)

Country Link
US (3) US10983135B2 (es)
EP (1) EP3411720A4 (es)
JP (3) JP7134870B2 (es)
KR (1) KR20180101595A (es)
CN (2) CN114441773A (es)
AU (1) AU2017214469A1 (es)
BR (1) BR112018015698A2 (es)
CA (1) CA3012192A1 (es)
MA (1) MA43980A (es)
MX (1) MX2018009304A (es)
RU (1) RU2018130866A (es)
SG (1) SG11201805906WA (es)
WO (1) WO2017136464A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3411720A4 (en) 2016-02-01 2019-08-14 Prevencio, Inc. DIAGNOSIS AND PROGNOSIS PROCEDURE FOR HEART CIRCULAR DISEASES AND EVENTS
WO2019055609A1 (en) * 2017-09-14 2019-03-21 University Of Alabama At Birmingham BIOMARKERS AND METHODS OF RISK ASSESSMENT OF MYOCARDIAL INFARCTION AND SEVERE INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS
EP3704491A4 (en) * 2017-11-02 2021-12-01 Prevencio, Inc. DIAGNOSTIC AND PROGNOSTIC METHODS OF PERIPHERAL ARTERIAL DISEASE, AORTIC STENOSIS, AND RESULTS
CN110232975A (zh) * 2019-05-20 2019-09-13 郑州大学第一附属医院 一种对糖尿病肾病患者3年内进入到肾脏替代治疗风险预测的方法
CN110491512A (zh) * 2019-08-08 2019-11-22 郑州大学第一附属医院 一种对肾活检确诊糖尿病肾病患者3年内进入到终末期肾脏病风险预测的方法
CN110596399B (zh) * 2019-08-29 2022-07-22 首都医科大学附属北京安贞医院 检测血管生成素样蛋白8含量的物质的应用
CN110970131B (zh) * 2019-10-24 2024-01-26 中国医科大学附属盛京医院 一种基于免疫球蛋白定量检测的肾小球疾病分类分型模型及其应用
RU2726314C1 (ru) * 2019-11-15 2020-07-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ раннего прогнозирования риска острого повреждения почек у пациентов с ишемической болезнью сердца после реваскуляризации миокарда методом аортокоронарного шунтирования
RU2760445C1 (ru) * 2020-11-13 2021-11-25 Виталий Юрьевич Мишланов Способ диагностики патологических состояний человека
WO2022202360A1 (ja) * 2021-03-23 2022-09-29 テルモ株式会社 情報処理装置、情報処理方法およびプログラム
CN113342963B (zh) * 2021-04-29 2022-03-04 山东大学 一种基于迁移学习的服务推荐方法及***
RU2770550C1 (ru) * 2021-05-31 2022-04-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования сердечно-сосудистого риска с помощью определения уровня эстрогенов
WO2023192004A2 (en) * 2022-03-30 2023-10-05 Inflammatix, Inc. Methods for diagnosing myocardial infarction
CN115185936B (zh) 2022-07-12 2023-02-03 曜立科技(北京)有限公司 一种基于大数据的医疗临床数据质量分析***
CN114974576A (zh) * 2022-07-12 2022-08-30 曜立科技(北京)有限公司 一种基于元数据的心脑血管数疾病诊断管理***

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US20080202927A1 (en) 2000-11-03 2008-08-28 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
US20060228723A1 (en) 2002-01-16 2006-10-12 Keith Bradley System and method for electronic sensing of biomolecules
US20030134433A1 (en) 2002-01-16 2003-07-17 Nanomix, Inc. Electronic sensing of chemical and biological agents using functionalized nanostructures
US9234867B2 (en) 2003-05-16 2016-01-12 Nanomix, Inc. Electrochemical nanosensors for biomolecule detection
US8685711B2 (en) 2004-09-28 2014-04-01 Singulex, Inc. Methods and compositions for highly sensitive detection of molecules
US20080269346A1 (en) * 2005-02-17 2008-10-30 University Of Florida Research Foundation, Inc. B-Blocker Pharmacogenetics in Heart Failure
CN101495862A (zh) * 2005-06-24 2009-07-29 利兰·斯坦福青年大学托管委员会 诊断和监测动脉粥样硬化性心血管疾病的方法和组合物
US8093017B2 (en) * 2005-12-07 2012-01-10 Siemens Heathcare Diagnostics Inc. Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
WO2007123708A2 (en) * 2006-03-31 2007-11-01 Epitome Biosystems, Inc. Post translational modification pattern analysis
EP2030025A2 (en) * 2006-06-07 2009-03-04 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
WO2008045799A2 (en) 2006-10-06 2008-04-17 Nanomix, Inc. Electrochemical nanosensors for biomolecule detection
EP2084543B1 (de) * 2006-10-26 2017-10-18 B.R.A.H.M.S GmbH Risikostratifizierung des akuten koronarsyndroms mittels fragmenten / teilpeptiden des provasopressins, insbesondere copeptin oder neurophysin ii
WO2008131039A2 (en) 2007-04-16 2008-10-30 Board Of Regents, The University Of Texas System Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
US8241861B1 (en) * 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
BRPI1009049A2 (pt) 2009-06-04 2016-03-08 Koninkl Philips Electronics Nv "sistema estruturado para facilitar a terapia comportamental cognitiva para um paciente apresentando insônia"
WO2010144358A1 (en) * 2009-06-08 2010-12-16 Singulex, Inc. Highly sensitive biomarker panels
US20120208715A1 (en) 2009-08-20 2012-08-16 Mcdevitt John T Methods and compositions for diagnosis of acute myocardial infarction (ami)
CA2783536A1 (en) * 2009-12-09 2011-06-16 Aviir, Inc. Biomarker assay for diagnosis and classification of cardiovascular disease
KR101256928B1 (ko) * 2010-01-20 2013-04-19 주식회사디엔에이링크 비만 또는 당뇨에 관련된 단일염기다형성 및 그의 용도
CN103502795B (zh) 2011-03-09 2016-02-24 阿比奥尼克公司 选择性功能化的纳米流体生物传感器中的生物分子的快速定量及其方法
WO2012145037A1 (en) * 2011-04-19 2012-10-26 Scott & White Healthcare Novel apoc-i isoforms and their use as biomarkers and risk factors of atherosclerotic disease
US20140011811A1 (en) * 2011-10-06 2014-01-09 The United States Government As Represented By The Department Of Veterans Affairs Myosin binding protein-c for use in methods relating to diastolic heart failure
WO2014078615A1 (en) * 2012-11-16 2014-05-22 Siemens Healthcare Diagnostics Inc. Method to identify optimum coronary artery disease treatment
US20160146834A1 (en) 2013-07-12 2016-05-26 Emory University Diagnostic assay to predict cardiovascular risk
WO2015007559A1 (en) 2013-07-17 2015-01-22 Abionic Sa Method and device for bioassays
US20150160229A1 (en) * 2013-12-06 2015-06-11 Thomas D. Schaal Methods for detection of heart failure
WO2015171989A1 (en) 2014-05-08 2015-11-12 University Of Maryland, Baltimore Methods for assessing differential risk for developing heart failure
CN106573240B (zh) 2014-07-03 2020-05-01 阿比奥尼克公司 用于诸如全血的流体试样的快速分子定量的胶囊
EP3411720A4 (en) 2016-02-01 2019-08-14 Prevencio, Inc. DIAGNOSIS AND PROGNOSIS PROCEDURE FOR HEART CIRCULAR DISEASES AND EVENTS

Also Published As

Publication number Publication date
JP2021128177A (ja) 2021-09-02
JP2022171936A (ja) 2022-11-11
US10983135B2 (en) 2021-04-20
BR112018015698A2 (pt) 2018-12-26
EP3411720A1 (en) 2018-12-12
KR20180101595A (ko) 2018-09-12
JP2019507354A (ja) 2019-03-14
CN114441773A (zh) 2022-05-06
JP7134870B2 (ja) 2022-09-12
MA43980A (fr) 2018-12-12
AU2017214469A1 (en) 2018-07-26
CN108700596A (zh) 2018-10-23
EP3411720A4 (en) 2019-08-14
US20190369120A1 (en) 2019-12-05
RU2018130866A (ru) 2020-03-04
WO2017136464A1 (en) 2017-08-10
CA3012192A1 (en) 2017-08-10
US20230341418A1 (en) 2023-10-26
US11977083B2 (en) 2024-05-07
JP7403498B2 (ja) 2023-12-22
SG11201805906WA (en) 2018-08-30
US20210072260A1 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
MX2018009304A (es) Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares.
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
WO2018208091A3 (ko) 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
WO2014107599A3 (en) Compositions and methods for detecting protease activity in biological systems
MX2016013255A (es) Metodos y composiciones para detectar proteinas mal plegadas.
MX2021012347A (es) Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica.
EA201500080A1 (ru) Способ in vitro диагностирования и мониторинга рака
MX2018000303A (es) Sistema y metodo de valoracion de la funcion endotelial.
BR102012002812A8 (pt) método para determinar a influência de uma variável em um fenômeno
MY195045A (en) Specific Biomarker Set For Non-Invasive Diagnosis of Liver Cancer
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
HK1250751A1 (zh) 基於脂肪組織樣本預測和/或診斷疾病的方法及方法套件
WO2014177867A3 (en) Differentially expressed biomarkers for alzheimer's disease
GB2552271A (en) A method for diagnosing lung cancer
MX2016001948A (es) Método para diagnosticar un tumor pulmonar maligno.
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
WO2015085164A3 (en) Uveal melanoma prognosis
WO2015006657A8 (en) Method for the diagnosis and prognosis of cancer
IN2014DN08312A (es)
WO2014143794A3 (en) Diagnostic and prognostic marker for prostate cancer
WO2014198670A3 (en) Methods of viewing and analyzing high content biological data
WO2013017690A3 (en) Troponin based rule in and rule out algorithm of myocardial infarction
NZ743812A (en) Prognostic method and kits useful in said method